Home
Transitioning to lonapegsomatropin in pediatric GHD shows promise with individualized dosing and monitoring
Growth Hormone Deficiency
Transitioning to lonapegsomatropin in pediatric GHD shows promise with individualized dosing and monitoring
Lonapegsomatropin provides a promising option for managing pediatric growth hormone deficiency (GHD) with less frequent injections, but careful dose adjustments and monitoring of IGF-1 levels are essential to ensure effective and safe treatment, according to a study. The single-center, retrospective study evaluated the impact of transitioning from somatropin to lonapegsomatropin...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Videos
06 Nov, 2024
Courtney Reints, DNP, ARNP, CPNP-PC, a pediatric nurse practitioner at...
-Advertisement-
-Advertisement-
Contact
© 2025 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved